Regulation & law · 07/11/20061 min read

Seahawk Biosystems Corporation to Receive Exclusive Patent License for Pathogen Detection and Genetic Testing from US Department of the Navy

The US Department of the Navy has announced its intention to grant Seahawk Biosystems Corporation a non-transferable, exclusive license to develop and utilize technology for pathogen and toxin detection, genetic testing in food products, and disease diagnosis in various settings, including biodefense, anti-bioterrorism, and national security.